Global medical cannabis market is expected to reach USD 56.70 billion by 2026. Increasing application of cannabis derived products to control symptoms of various diseases is expected to fuel the demand for medical cannabis in the coming years.
Get Sample Report @ https://www.adroitmarketresearch.com/contacts/request-sample/864
Cannabis is effective in treatment of chronic pain, which is one of the leading medical conditions affecting a large portion of the American population. According to the National Health Interview Survey, more than 20 million people suffer from pain on daily basis within the U.S., with high economic burden of chronic pain. Medical cannabis is expected to show positive interventions in overcoming pain. Furthermore, increasing number of countries passing bills for legalization of medical marijuana is expected to spur the market growth in the years to come.
Continuous research on developing cannabis strains with highest medical value has been attracting large potential patient population. Additionally, various companies are concentrating on partnerships to expand their business and enter newer markets. For instance, in 2018, WeedMD partnered with Technion-Israel Institute of Technology for cannabis database project. The collaboration will research on cannabinoid & terpenoid profiles of WeedMD’s cannabis strains. Additionally, in 2017, the Oxford University declared its partnership with Kingsley Capital Partners, for developing marijuana based therapies for cancer, pain and many more disorders. These research initiatives are expected to change the perception of society towards cannabis and reduce social stigma.
The “Global Medical Cannabis Market Size by Indication (Pain Management, Neurological disorders, and others) by Region and Forecast 2016 to 2026” study provides an elaborative view of historic, present and forecasted market estimates.
Access the full report @ https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market
In terms of indication, pain management dominated the global market by contributing over 60% of revenue and is expected to maintain its dominance by 2026. Large number of patients with chronic pain opting for medical cannabis is expected to drive the segment growth in the coming years. Furthermore, cannabis has been showing positive results in management of neurological diseases such as Epilepsy, Parkinson’s, and Alzheimer’s. CNS relaxant properties of chemical compounds present in marijuana are shown to reduce seizures in various patients. Similar research evidence are expected to bring new patient pool under cannabis consumption.
In terms of regional demarcation, North America dominated the global market and is expected to retain its command through the forecast period. U.S. and Canada both are the major countries with legalized medical cannabis and large number of users too. High level of awareness regarding medical benefits of cannabis in disease management is expected to drive the regional market. However, Europe and Asia Pacific are expected to grow at a faster pace compared to North America owing to recent legalization in some countries and growth phase of the market.
As of 2018, North America dominates the global medical cannabis market by contributing over 90% of total revenue, of which majority comes from the U.S. Additionally, legalization in Canada is expected to grow at a faster CAGR compared to the U.S., on account of growth phase of Canadian market. The total number of patients using medical cannabis in Canada has increased in the past few quarters with corresponding increase in the number of licensed producers. This increase in number of medical cannabis users has led to a spike in revenues for companies. Such prevailing dynamics in the Canadian market is expected to attract investors in the coming years.
Make an Enquire to Buy This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/864
Segment overview of Global Medical Cannabis Market
Indication Overview, 2016-2026 (USD Million)
- Pain management
- Neurological disease
- Others
Regional Overview, 2016-2026 (USD Million)
- North America
- S
- Canada
- Europe
- Germany
- Spain
- Italy
- Asia Pacific
- Australia
- New Zealand
- Central & South America
- Mexico
- Uruguay
- Middle East & Africa
Lavender is another enormously effective and precious Natural Remedies for Benign Essential Tremor which can help to reduce the disease symptoms.
Neurology Ultrasonic Aspirators Market – IntroductionNeurology ultrasonic aspirators are surgical devices which make use of low frequency ultrasonic vibrations for dissection of tissues and aspiration of the surgical field.
A study published by the National Center for Biotechnology Information (NCBI) concluded that neurology ultrasonic aspirators are being used for the removal of brain tumors.
This technology is used for surgery in orbital, lacrimal, neurological disease related, and skull base disabilities.Standalone neurology ultrasonic aspirators allow users to independently control power and deliver precise fragmentation and irrigation with a single hand piece and suction.Request a PDF of Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=72315Global Neurology Ultrasonic Aspirators Market – Competitive LandscapeThe global neurology ultrasonic aspirators market is consolidated, with presence of small number major players.
Leading players in the global neurology ultrasonic aspirators market are Stryker Corporation, Cybersonics Inc., Meta Dynamic Inc., Xcellence Medical Technologies Pvt.
It has developed Sonopet iQ ultrasonic aspirator system which gives surgeons the capability to fragment, emulsify and aspirate soft tissue and bone during complex neurosurgical operations.Meta Dynamic, Inc.Founded in 2002 and headquartered in California, US, Meta Dynamic, Inc. is a firm that develops surgical navigation equipment for hospitals and surgical facilities in California.
It has developed the Sonoca ultrasonic aspirator which facilitates tumor resection and tissue removal by using cavitation effect.Global Neurology Ultrasonic Aspirators Market – DynamicsThe global neurology ultrasonic aspirators market is projected to be driven by rise in the number of deaths due to brain tumor and increase in number of traumatic brain injuries across the world.
Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Rare Neurological Disease Treatment market during the historical period of 2013 – 2017.
The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2018, and key prospects over the forecast period 2018 – 2028.The global rare neurological disease treatment market is projected to expand at a stellar CAGR of over 8.5% and is anticipated to grow 2.3x between 2018 and 2028.
Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the Rare Neurological Disease Treatment market, both at global and regional levels.
The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Rare Neurological Disease Treatment market.After reading the Rare Neurological Disease Treatment market report, readers get insight into:Major drivers and restraining factors, opportunities and challenges, and the competitive landscapeNew, promising avenues in key regionsNew revenue streams for all players in emerging marketsFocus and changing role of various regulatory agencies in bolstering new opportunities in various regionsDemand and uptake patterns in key industries of the Rare Neurological Disease Treatment marketNew research and development projects in new technologies in key regional marketsChanging revenue share and size of key product segments during the forecast periodTechnologies and business models with disruptive potentialRequest for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S_id=4594The Rare Neurological Disease Treatment market report offers assessment of prevailing opportunities in various regions and evaluates their shares of revenue by the end of different years of the assessment period.
Key regions covered comprise:North America (U.S., Canada)Latin America (Brazil, Mexico, Argentina, Rest of Latin America)Europe (Germany, Italy, France, U.K., Spain, Benelux, Russia, Rest of Europe)East Asia (China, Japan, South Korea)JapanAPEJ (China, India, Indonesia, Thailand, Singapore, Australia & New Zealand, Rest of Asia Pacific)South Asia & Oceania (India, Thailand, Indonesia, Malaysia, Australia & New Zealand, Rest of South Asia & Oceania)Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa, Rest of Middle East & Africa)The evaluation of the competitive landscape in the Rare Neurological Disease Treatment market covers the profile of the following top players:Novartis AGPfizer, Inc.Johnson & Johnson Services, IncBayer AGGlaxoSmithKline PlcSanofi S.A.Allergan PlcMerck & Co., Inc.othersTo expand the understanding of opportunities in the global Rare Neurological Disease Treatment market report looks at close quarters into the opportunities and new avenues in following key segments:Hospitals PharmaciesRetail Pharmacies & Drug StoresOnline PharmaciesIn addition to understanding the demand patterns of various Distribution Channel, the report on the RARE NEUROLOGICAL DISEASE TREATMENT market also enumerates trends expected to attract investments by other various associated industries.On the basis of Drug Class types, the Rare Neurological Disease Treatment market report offers insight into major adoption trends for the following segments:Anti-depressantsAnti-psychoticsCholinesterase InhibitorsBiologicsOthers (Anti-vertigo, anti-seizure)By Route of Administration,InjectableOralBy Disease Indication,Alzheimer’s DiseaseNarcolepsyMultiple SclerosisAmyotrophic Lateral SclerosisOthersThe global Rare Neurological Disease Treatment market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period.
In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.For More Detailed Information about Methodology @ https://www.factmr.com/connectus/sample?flag=RM_id=4594Some important questions that the Rare Neurological Disease Treatment market report tries to answer exhaustively are:Key strategic moves by various players in the Rare Neurological Disease Treatment market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares.Which strategies will enable top players in the Rare Neurological Disease Treatment market to expand their geographic footprints?Which new business models are expected to change the course of growth of key regional markets in near future?Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants?Which products segments have in recent years have seen new, lucrative application areas?What are COVID-19 implication on Rare Neurological Disease Treatment market and learn how businesses can respond, manage and mitigate the risks?Media Release: https://www.factmr.com/media-release/1367/global-rare-neurological-disease-treatment-market
Global telepsychiatry market was dominated by Europe in the year 2018 and is expected to show maintain its dominance over the forecast period.
The main reasons for the high incidence of mental health conditions in the U.S. are a lack of access to mental healthcare and prominent substance abuse-related challenges.Request a PDF sample of the Global Telepsychiatry Market Research Report @ https://www.adroitmarketresearch.com/contacts/request-sample/881Technological advancements have led to the growth of telemedicine market.
For instance, the number of mobile health applications related to mental health services has increased significantly, with recent estimates suggest that approximately 6% of all mobile health applications developed focus on providing mental health services to users; while an additional 11% of mobile health applications developed are dedicated to providing stress management solutions.The risks associated with using the internet in clinical psychiatry vary depending on the context and the extent of the role of internet in physician practice.
Interactive websites, for example, present more risk opportunities (e.g.
E-therapy is one of the internet's most controversial uses, and for several reasons, doctors may be cautious about it.Given the prevalence of mental health & substance-dependence issues in adults & children, it is not astonishing that individuals, their families & society as a whole face an enormous emotional and financial burden.
The economic effects of mental illness have an impact on personal income, the ability of ill people–and often their caregivers–to work, workplace productivity, and contributions to the national economy, as well as the use of treatment services and support.Browse the complete research report with Table of Contents @ https://www.adroitmarketresearch.com/industry-reports/telepsychiatry-marketProduct wise, routine telepsychiatry dominated the global telepsychiatry market in the year 2018 and is expected to maintain its dominance till 2025.
